Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients

Innate Immunity

Volumn 14, Issue 4, 2008, Pages 247-253

  Kallio, K A Elisa ^a   Buhlin, Kåre ^b   Jauhiainen, Matti ^c   Keva, Ritva ^a   Tuomainen, Anita M ^a   Klinge, Björn ^b   Gustafsson, Anders ^b   Pussinen, Pirkko J ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Infection; Inflammation; Lipoprotein subclasses; Lipoproteins; Periodontal disease; Teeth

Indexed keywords

CYTOKINE; HIGH DENSITY LIPOPROTEIN; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN; LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDODONTICS; ENDOTOXEMIA; FEMALE; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; MOUTH HYGIENE; OUTCOME ASSESSMENT; PERIODONTITIS; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; TOOTH EXTRACTION; ACTIVE TRANSPORT; BLOOD; CHEMISTRY; ENDOCYTOSIS; HOSPITALIZATION; IMMUNOLOGY; MACROPHAGE; MIDDLE AGED; PROTEIN BINDING;

ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT, ACTIVE; ENDOCYTOSIS; ENDOTOXEMIA; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MACROPHAGES; MALE; MIDDLE AGED; PERIODONTITIS; PROTEIN BINDING; SEVERITY OF ILLNESS INDEX;

EID: 58949100579     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425908095130     Document Type: Article

References (40)

1. Knuuttila M. Hampaiden kiinnityskudossairaudet. In: Suominen-Taipale L, Nordbland A, Vehkalahti M, Aromaa A. (eds) Suomalaisten aikuisten suunterveys, Terveys 2000-tutkimus. Finland: National Public Health Institute, 2004; B16; 88-97.
2. Kononen E., Paju S., Pussinen PJ et al. Population-based study of salivary carriage of periodontal pathogens in adults. J Clin Microbiol 2007; 45: 2446-2451.
3. Silver JG, Martin AW, McBride BC Experimental transient bacteraemias in human subjects with varying degrees of plaque accumulation and gingival inflammation. J Clin Periodontol 1977; 4: 92-99.
4. Geerts SO, Nys M., De MP et al. Systemic release of endotoxins induced by gentle mastication: Association with periodontitis severity. J Periodontol 2002; 73: 73-78.
5. Pussinen PJ, Vilkuna-Rautiainen T., Alfthan G. et al. Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide. Arterioscler Thromb Vasc Biol 2004; 24: 2174-2180.
6. Levels JH, Abraham PR, van den Ende A., van Deventer SJ Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun 2001; 69: 2821-2828.
7. Harris HW, Johnson JA, Wigmore SJ Endogenous lipoproteins impact the response to endotoxin in humans. Crit Care Med 2002; 30: 23-31.
8. Levine DM, Parker TS, Donnelly TM, Walsh A., Rubin AL In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci USA 1993; 90: 12040-12044.
9. Levels JH, Lemaire LC, van den Ende AE, van Deventer SJ, van Lanschot JJ Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure. Crit Care Med 2003; 31: 1647-1653.
10. Barcia AM, Harris HW Triglyceride-rich lipoproteins as agents of innate immunity. Clin Infect Dis 2005; 41(Suppl 7): S498-S503.
11. Brown MS, Goldstein JL Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983; 52: 223-261.
12. Lakio L., Lehto M., Tuomainen AM et al. Pro-atherogenic properties of lipopolysaccharide from the periodontal pathogen Actinobacillus actinomycetemcomitans. J Endotoxin Res 2006; 12: 57-64.
13. Stoll LL, Denning GM, Weintraub NL Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 2227-2236.
14. Mattila KJ, Nieminen MS, Valtonen VV et al. Association between dental health and acute myocardial infarction. BMJ 1989; 298: 779-781.
15. Beck J., Garcia R., Heiss G., Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996; 67: 1123-1137.
16. Howell TH, Ridker PM, Ajani UA, Hennekens CH, Christen WG Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians. J Am Coll Cardiol 2001; 37: 445-450.
17. Desvarieux M., Demmer RT, Rundek T. et al. Periodontal microbiota and carotid intima-media thickness: The oral infections and vascular disease epidemiology study (INVEST). Circulation 2005; 111: 576-582.
18. Spahr A., Klein E., Khuseyinova N. et al. Periodontal infections and coronary heart disease: Role of periodontal bacteria and importance of total pathogen burden in the coronary event and periodontal disease (CORODONT) study. Arch Intern Med 2006; 166: 554-559.
19. Pussinen PJ, Nyyssonen K., Alfthan G., Salonen R., Laukkanen JA, Salonen JT Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler Thromb Vasc Biol 2005; 25: 833-838.
20. Li L., Messas E., Batista EL, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002; 105: 861-867.
21. Lalla E., Lamster IB, Hofmann MA et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003; 23: 1405-1411.
22. Brodala N., Merricks EP, Bellinger DA et al. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 2005; 25: 1446-1451.
23. Tuomainen AM, Jauhiainen M., Kovanen PT, Metso J., Paju S., Pussinen PJ Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice. Microb Pathog 2008; 44: 111-117.
24. Wiedermann CJ, Kiechl S., Dunzendorfer S. et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: Prospective results from the Bruneck study. J Am Coll Cardiol 1999; 34: 1975-1981.
25. Nyman S., Lindhe J. Clinical periodontology and implant dentistry. In: Lindhe J, Karring T, Lang NP. (eds) Clinical Periodontology and Implant Dentistry, 4th edn. Copenhagen: Blackwell Munksgaard, 2003; 403-413.
26. Love WD, Ramirez JM, Fultz RP An oral hygiene measurement system for possible research and clinical use. J Public Health Dent 1975; 35: 227-230.
27. Havel RJ, Eder HA, Bragdon JH The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345-1353.
28. Goto T., Eden S., Nordenstam G., Sundh V., Svanborg-Eden C., Mattsby-Baltzer I. Endotoxin levels in sera of elderly individuals. Clin Diagn Lab Immunol 1994; 1: 684-688.
29. Pussinen PJ, Tuomisto K., Jousilahti P., Havulinna AS, Sundvall J., Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol 2007; 27: 1433-1439.
30. Guidet B., Barakett V., Vassal T., Petit JC, Offenstadt G. Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit. Chest 1994; 106: 1194-1201.
31. Kitchens RL, Thompson PA, Munford RS, O'Keefe GE Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res 2003; 44: 2339-2348.
32. Stollenwerk MM, Schiopu A., Fredrikson GN, Dichtl W., Nilsson J., Ares MP Very low density lipoprotein potentiates tumor necrosis factor-alpha expression in macrophages. Atherosclerosis 2005; 179: 247-254.
33. Jia L., Takahashi M., Morimoto H. et al. Changes in cardiac lipid metabolism during sepsis: The essential role of very low-density lipoprotein receptors. Cardiovasc Res 2006; 69: 545-555.
34. Bansal S., Buring JE, Rifai N., Mora S., Sacks FM, Ridker PM Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007; 298: 309-316.
35. Nordestgaard BG, Benn M., Schnohr P., Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298: 299-308.
36. Skipski VP, Barclay M., Barclay RK, Fetzer VA, Good JJ, Archibald FM Lipid composition of human serum lipoproteins. Biochem J 1967; 104: 340-352.
37. Funk JL, Feingold KR, Moser AH, Grunfeld C. Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis 1993; 98: 67-82.
38. Nordestgaard BG, Zilversmit DB Hyperglycemia in normotriglyceridemic, hypercholesterolemic insulin-treated diabetic rabbits does not accelerate atherogenesis. Atherosclerosis 1988; 72: 37-47.
39. Sammalkorpi K., Valtonen V., Kerttula Y., Nikkila E., Taskinen MR Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988; 37: 859-865.
40. Kiechl S., Egger G., Mayr M. et al. Chronic infections and the risk of carotid atherosclerosis: Prospective results from a large population study. Circulation 2001; 103: 1064-1070.